Fast track multi-discipline treatment (FTMDT trial) versus conventional treatment in colorectal cancer--the design of a prospective randomized controlled study

Jiao-Jiao Zhou, Jun Li, Xiao-Jiang Ying, Yong-Mao Song, Rong Chen, Gang Chen, Min Yan, Ke-Feng Ding, Jiao-Jiao Zhou, Jun Li, Xiao-Jiang Ying, Yong-Mao Song, Rong Chen, Gang Chen, Min Yan, Ke-Feng Ding

Abstract

Background: Laparoscopy-assisted surgery, fast-track perioperative treatment are both increasingly used in colorectal cancer treatment, for their short-time benefits of enhanced recovery and short hospital stays. However, the benefits of the integration of the Laparoscopy-assisted surgery, fast-track perioperative treatment, and even with the Xelox chemotherapy, are still unknown. In this study, the three treatments integration is defined as "Fast Track Multi-Discipline Treatment Model" for colorectal cancer and this model extends the benefits to the whole treatment process of colorectal cancer. The main purpose of the study is to explore the feasibility of "Fast Track Multi-Discipline Treatment" model in treatment of colorectal cancer.

Methods: The trial is a prospective randomized controlled study with 2 × 2 balanced factorial design. Patients eligible for the study will be randomized to 4 groups: (I) Laparoscopic surgery with fast track perioperative treatment and Xelox chemotherapy; (II) Open surgery with fast track perioperative treatment and Xelox chemotherapy; (III) Laparoscopic surgery with conventional perioperative treatment and mFolfox6 chemotherapy; (IV) Open surgery with conventional perioperative treatment and mFolfox6 chemotherapy. The primary endpoint of this study is the hospital stays. The secondary endpoints are the quality of life, chemotherapy related adverse events, surgical complications and hospitalization costs. Totally, 340 patients will be enrolled with 85 patients in each group.

Conclusions: The study initiates a new treatment model "Fast Track Multi-Discipline Treatment" for colorectal cancer, and will provide feasibility evidence on the new model "Fast Track Multi-Discipline Treatment" for patients with colorectal cancer.

Trial registration: ClinicalTrials.gov: NCT01080547.

Figures

Figure 1
Figure 1
The FTMDT trial flowchart.

References

    1. Clinical Outcomes of Surgical Therapy Study Group. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med. 2004;350(20):2050–2059.
    1. Leung KL, Kwok SP, Lam SC, Lee JF, Yiu RY, Ng SS, Lai PB, Lau WY. Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial. Lancet. 2004;363(9416):1187–1192. doi: 10.1016/S0140-6736(04)15947-3.
    1. Neudecker J, Klein F, Bittner R, Carus T, Stroux A, Schwenk W. LAPKON II trialists: short-term outcomes from a prospective randomized trial comparing laparoscopic and open surgery for colorectal cancer. Br J Surg. 2009;96(12):1458–1467. doi: 10.1002/bjs.6782.
    1. Hewett PJ, Allardyce RA, Bagshaw PF, Frampton CM, Frizelle FA, Rieger NA, Smith JS, Solomon MJ, Stephens JH, Stevenson AR. Short-term outcomes of the Australasian randomized clinical study comparing laparoscopic and conventional open surgical treatments for colon cancer: the ALCCaS trial. Ann Surg. 2008;248(5):728–738. doi: 10.1097/SLA.0b013e31818b7595.
    1. Basse L, Hjort Jakobsen D, Billesbølle P, Werner M, Kehlet H. A clinical pathway to accelerate recovery after colonic resection. Ann Surg. 2000;232(1):51–57. doi: 10.1097/00000658-200007000-00008.
    1. Wilmore DW, Kehlet H. Management of patients in fast track surgery. BMJ. 2001;322(7284):473–476. doi: 10.1136/bmj.322.7284.473.
    1. Kehlet H. Fast-track colonic surgery: status and perspectives. Recent Results Cancer Res. 2005;165:8–13. doi: 10.1007/3-540-27449-9_2.
    1. Fearon KC, Ljungqvist O, Von Meyenfeldt M, Revhaug A, Dejong CH, Lassen K, Nygren J, Hausel J, Soop M, Andersen J, Kehlet H. Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection. Clin Nutr. 2005;24(3):466–477. doi: 10.1016/j.clnu.2005.02.002.
    1. Laparoscopy and/or Fast Track Multimodal Management Versus Standard Care (LAFA) Study Group and the Enhanced Recovery after Surgery (ERAS) Group. Systematic review of enhanced recovery programmes in colonic surgery. Br J Surg. 2006;93(7):800–809. doi: 10.1002/bjs.5384.
    1. Kehlet H, Wilmore DW. Evidence-based surgical care and the evolution of fast-track surgery. Ann Surg. 2008;248(2):189–198. doi: 10.1097/SLA.0b013e31817f2c1a.
    1. Counihan TC, Favuzza J. Fast track colorectal surgery. Clin Colon Rectal Surg. 2009;22(1):60–72. doi: 10.1055/s-0029-1202888.
    1. Enhanced Recovery After Surgery (ERAS) Group. Consensus review of optimal perioperative care in colorectal surgery: enhanced recovery after surgery (ERAS) group recommendations. Arch Surg. 2009;144(10):961–969. doi: 10.1001/archsurg.2009.170.
    1. Gouvas N, Tan E, Windsor A, Xynos E, Tekkis PP. Fast-track vs standard care in colorectal surgery: a meta-analysis update. Int J Colorectal Dis. 2009;24(10):1119–1131. doi: 10.1007/s00384-009-0703-5.
    1. Eskicioglu C, Forbes SS, Aarts MA, Okrainec A, McLeod RS. Enhanced recovery after surgery (ERAS) programs for patients having colorectal surgery: a meta-analysis of randomized trials. J Gastrointest Surg. 2009;13(12):2321–2329. doi: 10.1007/s11605-009-0927-2.
    1. Schmoll HJ, Cartwright T, Tabernero J, Nowacki MP, Figer A, Maroun J, Price T, Lim R, Van Cutsem E, Park YS, McKendrick J, Topham C, Soler-Gonzalez G, de Braud F, Hill M, Sirzén F, Haller DG. Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients. J Clin Oncol. 2007;25(1):102–109.
    1. Cassidy J, Tabernero J, Twelves C, Brunet R, Butts C, Conroy T, Debraud F, Figer A, Grossmann J, Sawada N, Schöffski P, Sobrero A, Van Cutsem E, Díaz-Rubio E. XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer. J Clin Oncol. 2004;22(11):2084–2091. doi: 10.1200/JCO.2004.11.069.
    1. Haller D, Tabernero J, Maroun J, de Braud F, Price T, Van Cutsem E, Hill M, Gilberg F, Rittweger K, Schmoll H. First efficacy findings from a randomized phase III trial of capecitabine + oxaliplatin versus bolus 5-FU/LV for stage III colon cancer (NO16968/XELOXA study)[abstract 5LBA] Eur J Cancer. 2009;7(3 suppl):4.
    1. Enhanced Recovery After Surgery (ERAS) Group. Length of stay: an inappropriate readout of the success of enhanced recovery programs. World J Surg. 2008;32(6):971–975. doi: 10.1007/s00268-007-9404-9.
    1. Zutshi M, Delaney CP, Senagore AJ, Mekhail N, Lewis B, Connor JT, Fazio VW. Randomized controlled trial comparing the controlled rehabilitation with early ambulation and diet pathway versus the controlled rehabilitation with early ambulation and diet with preemptive epidural anesthesia/analgesia after laparotomy and intestinal resection. Am J Surg. 2005;189(3):268–272. doi: 10.1016/j.amjsurg.2004.11.012.
    1. Otchy D, Hyman NH, Simmang C, Anthony T, Buie WD, Cataldo P, Church J, Cohen J, Dentsman F, Ellis CN, Kilkenny JW, Ko C, Moore R, Orsay C, Place R, Rafferty J, Rakinic J, Savoca P, Tjandra J, Whiteford M. Standards practice task force; American society of colon and rectal surgeons: practice parameters for colon cancer. Dis Colon Rectum. 2004;47(8):1269–1284. doi: 10.1007/s10350-004-0598-8.
    1. Tjandra JJ, Kilkenny JW, Buie WD, Hyman N, Simmang C, Anthony T, Orsay C, Church J, Otchy D, Cohen J, Place R, Denstman F, Rakinic J, Moore R, Whiteford M. Standards practice task force; American society of colon and rectal surgeons: practice parameters for the management of rectal cancer (revised) Dis Colon Rectum. 2005;48(3):411–423.
    1. Raue W, Haase O, Junghans T, Scharfenberg M, Müller JM, Schwenk W. 'Fast-track' multimodal rehabilitation program improves outcome after laparoscopic sigmoidectomy: a controlled prospective evaluation. Surg Endosc. 2004;18(10):1463–1468. doi: 10.1007/s00464-003-9238-y.
    1. King PM, Blazeby JM, Ewings P, Franks PJ, Longman RJ, Kendrick AH, Kipling RM, Kennedy RH. Randomized clinical trial comparing laparoscopic and open surgery for colorectal cancer within an enhanced recovery programme. Br J Surg. 2006;93(3):300–308. doi: 10.1002/bjs.5216.
    1. Carli F, Charlebois P, Baldini G, Cachero O, Stein B. An integrated multidisciplinary approach to implementation of a fast-track program for laparoscopic colorectal surgery. Can J Anaesth. 2009;56(11):837–842. doi: 10.1007/s12630-009-9159-x.
    1. Patel GN, Rammos CK, Patel JV, Estes NC. Further reduction of hospital stay for laparoscopic colon resection by modifications of the fast-track care plan. Am J Surg. 2010;199(3):391–394. doi: 10.1016/j.amjsurg.2009.09.009. discussion 394-395.
    1. Tsikitis VL, Holubar SD, Dozois EJ, Cima RR, Pemberton JH, Larson DW. Advantages of fast-track recovery after laparoscopic right hemicolectomy for colon cancer. Surg Endosc. 2010;24(8):1911–1916. doi: 10.1007/s00464-009-0871-y.
    1. Ding KF, Chen R, Zhang JL, Li J, Xu YQ, Lv L, Wang XC, Sun LF, Wang JW, Zheng S, Zhang SZ. Laparoscopic surgery for the curative treatment of rectal cancer: results of a Chinese three-center case-control study. Surg Endosc. 2009;23(4):854–861. doi: 10.1007/s00464-008-9990-0.
    1. Li M, Gu J. Changing patterns of colorectal cancer in China over a period of 20 years. World J Gastroenterol. 2005;11(30):4685–4688.
    1. NCCN clinical practice guidelines in oncology-colon cancer guideline 2009 (Version2.2009)
    1. Jayne DG, Guillou PJ, Thorpe H, Quirke P, Copeland J, Smith AM, Heath RM, Brown JM. UKMRC CLASICC Trial Group. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC trial group. J Clin Oncol. 2007;25(21):3061–3068. doi: 10.1200/JCO.2006.09.7758.
    1. Li J, Chen R, Xu YQ, Wang XC, Zheng S, Zhang SZ, Ding KF. Impact of a laparoscopic resection on the quality of life in rectal cancer patients: results of 135 patients. Surg Today. 2010;40(10):917–922. doi: 10.1007/s00595-009-4156-9.
    1. Ding KF, Ying XJ, Li J, Li G, Chen ZL, Wang ZH, Lv K, Zhou JJ, Ma YY, Zhang SZ. The interim analysis of an open nonrandomized prospective study comparing laparoscopic surgery with XELOX chemotherapy and open surgery with mFOLFOX6 chemotherapy for resectable colorectal cancer [abstract 693] Ann Oncol. 2010;21(suppl 8):viii220.
    1. MacKay G, Ihedioha U, McConnachie A, Serpell M, Molloy RG, O'Dwyer PJ. Laparoscopic colonic resection in fast-track patients does not enhance short-term recovery after elective surgery. Colorectal Dis. 2007;9(4):368–372. doi: 10.1111/j.1463-1318.2006.01123.x.
    1. Bartels SA, Vlug MS, Ubbink DT, Bemelman WA. Quality of life after laparoscopic and open colorectal surgery: a systematic review. World J Gastroenterol. 2010;16(40):5035–5041. doi: 10.3748/wjg.v16.i40.5035.
    1. Khan S, Gatt M, MacFie J. Enhanced recovery programmes and colorectal surgery: does the laparoscope confer additional advantages? Colorectal Dis. 2009;11(9):902–908. doi: 10.1111/j.1463-1318.2009.01781.x.
    1. Wind J, Hofland J, Preckel B, Hollmann MW, Bossuyt PM, Gouma DJ, van Berge Henegouwen MI, Fuhring JW, Dejong CH, van Dam RM, Cuesta MA, Noordhuis A, de Jong D, van Zalingen E, Engel AF, Goei TH, de Stoppelaar IE, van Tets WF, van Wagensveld BA, Swart A, van den Elsen MJ, Gerhards MF, de Wit LT, Siepel MA, van Geloven AA, Juttmann JW, Clevers W, Bemelman WA. Perioperative strategy in colonic surgery; LAparoscopy and/or FAst track multimodal management versus standard care (LAFA trial) BMC Surg. 2010;29:6–16.
    1. Winterhalder R, Delmore G, Hardegger T, Urspruch A, Hieke K. Cost comparison: capecitabine + oxaliplatin(XELOX) vs 5-FU/LV + oxaliplatin (FOLFOX4) in the adjuvant treatment of patients with colon cancer(ACC)[abstract 622P] Ann Oncol. 2010;21(suppl 8):viii201.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다